期刊文献+

幽门螺杆菌疫苗口服免疫小鼠后胃肠免疫应答研究 被引量:4

STUDY OF GASTROINTESTINAL IMMUNE RESPONSES IN BALB/c MICE BY ORAL IMMUNIZATION WITH HELICOBACTER PYLORI
下载PDF
导出
摘要 为探讨Hp全菌抗原和粘膜佐剂LT口服免疫BALB/c小鼠后的胃肠免疫反应 ,采用ELISPOT和ELISA法检测免疫小鼠胃粘膜、派伊尔小结抗原特异性抗体形成细胞 (AFC)和小肠粘液sIgA。结果显示 ,免疫小鼠胃粘膜、派伊尔小结抗原特异性抗体形成细胞数量明显增加 ,抗原 +佐剂组AFC数量高于单纯抗原免疫组和对照组 ,尤以sIgA AFC为甚 ;小肠粘液特异sIgA两免疫组均明显高于对照组。本研究结果表明 ,口服免疫可有效诱导胃肠道粘膜免疫 。 To study the gastrointestinal immune responses in BALB/c mice administered orally Hp sonicates and mucosal adjuvant( LT). The changes of antigen specific antibody forming cell (AFC) in gastric mucosa and Peyer , patch (PP)were detected by ELISPOT and sIgA of gut washing by ELISA. The results showed that the amounts of sIgA and IgG AFC especialy sIgA-AFC increased significantly in PP and gastric mucosa.The level of specific sIgA also increased obviously . Significant differences were observed between two immunized groups and the control. It suggested that oral immunization can effectively induce gastrointestinal mucosal immune,and that locally synthesized specific sIgA antibodies may contribute to immunity against gastric Helicobacter infection.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2001年第3期195-197,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家"九五"重点攻关课题! (编号 96 90 1 0 1 5 4) 全军"九五"医药卫生科研基金资助课题! (编号 98D0 0 4)
关键词 幽门螺杆菌 佐剂 免疫 抗体形成细胞 胃肠免疫应答 疫苗 Helicobacter pylori adjuvants,immunologic antibody forming cell(AFC)
  • 相关文献

参考文献1

共引文献11

同被引文献32

  • 1殷国荣,元海军,杨亚波,周永安,沈嬿琼,孟晓丽.TSo联合IFN-γ鼻内免疫小鼠诱导的弓形虫IgA抗体特异性免疫应答[J].热带医学杂志,2004,4(6):670-673. 被引量:25
  • 2Halina Wedrychowicz,舒衡平.胃肠道寄生虫感染中的分泌型IgA[J].国外医学(寄生虫病分册),1996,23(4):156-158. 被引量:2
  • 3[4]Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases[J]. Rev Med Virol, 2001, 11(2): 117- 133.
  • 4[5]Lloyd Kaspera, Nathalie Courretb, Sylvie Darchec, et al. Toxoplasma gondii and mucosal immunity[J]. Int J for Parasitol,2004, 34:401- 409.
  • 5[6]Briskin M, Winsor HD, Shyjan A, et al. Human mucosal addressin cell adhesion molecule is preferentially expressed in intestinal tract and associated lymphoid tissue [J]. Am J Pathol, 1997, 151:97- 110.
  • 6[7]Suzuki Y. IFN-γ : the major mediator of resistance against Toxoplasma gondii [J]. Science, 1988, 240:516- 523.
  • 7[9]Debard N, Buzoni- Gatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebal cyst after oral infection[J]. Infect Immun, 1996, 64 (6): 2158- 2166.
  • 8[10]Velge- Roussel F, Marcelo P, Bout DT, et al. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments[J]. Infect Immun, 2000, 68 (2): 969- 972.
  • 9[11]Bonenfant C, Dimier- Poisson I, Velge- Roussel F, et al. Intranasal I immunization with SAG1 and nontoxic mutant heat- labile enterotoxins protects mice against Toxoplasma gondii [J]. Infect Immun, 2001, 69(4): 1605- 1612.
  • 10[13]Chardes T, Bourguin I, Mevelec MN, et al. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens[J]. Infect Immun, 1990, 58(5):1240- 1246.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部